This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The evolution of preclinical models for myelodysplastic neoplasms
Leukemia Open Access 23 February 2024
-
Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia
Bone Marrow Transplantation Open Access 22 January 2024
-
In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice
Nature Biotechnology Open Access 26 January 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shultz LD, Ishikawa F, Greiner DL . Humanized mice in translational biomedical research. Nature Reviews 2007; 7: 118–130.
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175–3182.
Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174: 6477–6489.
Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE . Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors. Leukemia 2003; 17: 760–763.
Nicolini FE, Cashman JD, Hogge DE, Humphries RK, Eaves CJ . NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia 2004; 18: 341–347.
Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhelm JS et al. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 2008; 13: 483–495.
Mulloy JC, Cammenga J, Berguido FJ, Wu K, Zhou P, Comenzo RL et al. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood 2003; 102: 4369–4376.
Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA, Nimer SD . The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood 2002; 99: 15–23.
Wunderlich M, Krejci O, Wei J, Mulloy JC . Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability. Blood 2006; 108: 1690–1697.
Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR et al. A robust xenotransplantation model for acute myeloid leukemia. Leukemia 2009; 23: 2109–2117.
Acknowledgements
We thank Leonard Shultz for help with the IL2RG PCR conditions, the Comprehensive Mouse and Cancer Core of Cincinnati Children's Hospital for help with mouse experiments, Susumu Goyama for valuable discussion and suggestions, and Christina Sexton and Mahesh Shrestha for technical assistance. This study was supported by NIH grants CA118319 and CA140518, Gabrielle's Angel Foundation for Cancer Research and DOD Grant PR081404 (JCM). MC was supported in part by the Art Rhodes Fund for Leukemia Research at the Abramson Cancer Institute of the University of Pennsylvania.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wunderlich, M., Chou, FS., Link, K. et al. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 24, 1785–1788 (2010). https://doi.org/10.1038/leu.2010.158
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.158
This article is cited by
-
Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia
Bone Marrow Transplantation (2024)
-
The evolution of preclinical models for myelodysplastic neoplasms
Leukemia (2024)
-
Humanized mouse models for immuno-oncology research
Nature Reviews Clinical Oncology (2023)
-
In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice
Nature Biotechnology (2023)
-
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Blood Cancer Journal (2022)